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FADD = Fas associated death domain protein; IFN = interferon; IL = interleukin; IRAK = interleukin-1 receptor associated kinase; LBP =
lipopolysaccharide-binding protein; LPS = lipopolysaccharide; NF-κB = nuclear factor-κB; RIP = receptor interacting protein; TAK = transforming
growth factor-β activated kinase; TIR = Toll/IL-1/resistance; TLR = Toll-like receptor; TNF = tumor necrosis factor; TRADD = TNF-receptor associ-
ated death domain protein; TRAF = tumor necrosis factor receptor associated factor.
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The revelation that germs cause disease did not much alter
medicine at first. Many years elapsed before the first effective
systemic antimicrobial agents were designed and used in
human patients. Although it was an enormous advance,
antimicrobial chemotherapy did not put an end to the problem
of infections, or certainly to the consequences of infections.
As the science of microbial pathogenesis advanced, the toxic
molecules produced by bacteria and fungi that are responsi-
ble for injury to the host were elucidated one by one. Some of
the toxins are proteinaceous and are apparently ‘intended’ as
weapons. Others, however, are structural components of the
microbe, and are toxic only because the host ‘chooses’ to
view them as such.
Endotoxin was the first molecule of the latter category to be
recognized, but peptidoglycan, lipoteichoic acid, various
lipopeptides, and even the DNA that serves as a repository of
genetic information for the microbe can provoke untoward
responses in the mammalian host. As to the element of
‘choice’ that the host has made in viewing such molecules as
toxic, a certain logic has become clear. The innate immune
response is based on recognition of conserved molecules of
microbial origin. The innate immune response is also
intended, in the vast majority of cases in which it is invoked,
to contain limited infections, caused by small inocula of
microbes. The evolutionary calculation has therefore been
one in which a very intense response is waged against local-
ized infection, even though a large infection, provoking a
similar response at a systemic level, may prove to be fatal.
The innate immune system is largely based on myeloid cells
that are endowed with the ability to engulf and kill microbes
that have invaded the interior milieu of the host. Some cells,
such as the neutrophil, are particularly ferocious in their ability
to destroy bacteria, but are very short lived and tend to
remain within the confines of the circulatory system, exiting
only when they are summoned by signals that emanate from
the extravascular compartment. Other cells of the innate
immune system, including the macrophage and the dendritic
cell, are also active phagocytes, and are quite capable of
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Abstract
A pure reductionist approach can sometimes be used to solve an exceptionally complicated biologic
problem, and sepsis is nothing if not complicated. A serious infection promptly leads to changes in
many aspects of host physiology, including alterations in circulation, metabolism, renal, hepatic, and
neuroendocrine function; all of these changes happen at once, and each influences one another. It is
difficult to tease apart a problem of this sort, if only because the systems affected are so profoundly
interactive. The key to understanding sepsis, insofar as we do understand it at present, was found in
the use of genetic tools to study the very earliest events that take place at the interface of the pathogen
and the host. The continued application of both forward and reverse genetic methods, in both
mammals and insects, is steadily revealing the central biochemical events that occur during infection.
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killing bacteria. However, they serve a dual function in that
they elaborate cytokines to give warning of infection both
near and far, and also contribute to the adaptive immune
response, which is based on nonphagocytic lymphoid cells.
Natural killer cells, which are also lymphoid, may be viewed as
a rather recently emergent component of the innate immune
system, and are now known to play a vital role in defense
against certain viruses.
The central purpose of the present review is to discuss the
molecular pathways through which the host first becomes
aware of infection, and the links that exist between this affer-
ent system and the response per se. The genetic methods
that are being used to elucidate the key molecules involved in
detecting and responding to infection are also described in
some detail.
Microbial sensing in the extracellular
compartment
Before microbes or any of their component molecules ever
had direct contact with cells of the innate immune system,
they could be detected by proteins that were retained in evo-
lution for this express purpose. Complement, for example, can
be activated and fixed on the surface of microbes via prop-
erdin, or released from leukocytes [1] or the mannan associ-
ated serine protease pathway (in which mannose binding
protein interacts with a serine protease that triggers the com-
plement cascade) [2–5]. Activation of complement can lead
to destruction of bacteria and to release of bacterial mole-
cules that can activate cell-associated components of the
system for microbial sensing.
The mannose binding lectin in plasma engages mannosyl
residues that are typically found on fungi and bacteria. It is
not alone, however, and other soluble proteins engage in
direct contact with invasive pathogens to elicit an immune
response. In mammals, at least one soluble form of peptido-
glycan recognition protein is also known to bind tightly to
bacteria [6,7] and may contribute to bacterial recognition,
although a role in defense has yet to be established experi-
mentally. In 1990, it was shown that lipopolysaccharide (LPS)
from Gram-negative bacteria is tightly engaged by a plasma
protein called LPS-binding protein (LBP) [8]. LBP conveys
LPS to the surface of the cell, where it is transferred to CD14
[9], a leucine rich protein that is anchored to the lipid bilayer
by a glycophosphatidylinositol group. CD14 can also exist as
a soluble protein and, in this case also, it can convey LPS to
the cell surface. It is an important part of the host LPS recog-
nition pathway [10].
Hence, before a microbe has ever had direct contact with a
mammalian cell, it is able to induce chemical reactions that
reveal its presence. However, it is the cellular response to
microbes that creates the septic syndrome, and a handful
of specific receptors alert the host to the presence of an
infection.
The effector limb of the response
During the decade of the 1980s, one of the key discoveries in
sepsis research concerned the role played by soluble mediators
of monocyte/macrophage origin in shock pathogenesis. Tumor
necrosis factor (TNF), purified from mouse macrophages as an
endotoxin induced mediator [11,12], was found to be one of the
most abundant macrophage secretory products and is pro-
duced within a very short period of time after LPS administration
[13]. Blocking TNF by passive immunization was shown to
render animals partially resistant to the lethal effect of LPS [14].
Furthermore, TNF could evoke many of the pathologic changes
caused by endotoxin and other microbial inducers [15]. These
observations suggested that TNF might act as one of a collec-
tion of endogenous mediators of endotoxicity.
TNF was known to synergize with IFN-γ in many of its effects
(i.e. in its cytolytic effect on certain cultured tumor lines [16]).
Moreover, IFN-γ greatly augments the production of TNF
induced by endotoxin in vivo or in vitro [17]. In subsequent
studies, knockout of the TNF p55 receptor [18] and knockout
of the IFN-γ receptor [19] produced marked resistance to the
lethal effect of LPS. It is likely that both TNF and IFN-γ, which
signal through very different pathways, contribute to the
development of shock in sepsis.
A third inflammatory cytokine, IL-1, has also been implicated
in the pathogenesis of inflammation and shock [20,21] and
appears to synergize with TNF, diminishing the 50% lethal
dose of the latter [22]. Although it lacks the toxicity of either
TNF or IFN-γ when administered by itself, IL-1 does mimic
TNF in a number of ways. For example, it suppresses the
expression of certain anabolic enzymes [23] and induces pro-
duction of proteases and prostaglandins [24] that contribute
to inflammation on a local level. The IL-1 receptor has Toll/IL-
1/resistance (TIR) domains similar to the Toll-like receptors
that are primarily responsible for transducing microbial
signals. On this basis, it might be assumed that the IL-1
receptor participates in an amplification loop (Fig. 1).
The TNF receptors are of two types. The p55 TNF receptor,
which is responsible for most of the toxicity of TNF, has a
death domain and as such is involved in activation of the
caspase cascade by means of intermediate transducers such
as receptor interacting protein (RIP) [25], TNF-receptor asso-
ciated death domain protein (TRADD) [26] and, indirectly,
Fas associated death domain protein (FADD) [27]. In addi-
tion, it activates nuclear factor-κB (NF-κB), a central tran-
scriptional activator of many proinflammatory genes
[18,26,28]. The p75 TNF receptor signals by way of TNF
receptor associated factor (TRAF) family members [29], and
also activates NF-κB, but is less involved in the cytolytic activ-
ity of TNF and in its toxic action [30]. The IFN-γ receptor acti-
vates a rather different collection of genes through interaction
with Janus kinase (JAK) family tyrosine kinases, which in turn
phosphorylate members of the STAT (signal transducer and
activator of transcription) family of transcription factors [31].41
The downstream effects of these cytokines are exceedingly
complicated. Together, however, they act to alter coagula-
tion, induce fever, and cause hypotension and tissue injury,
as is widely observed in septic shock. In part, they do so by
triggering the release of many secondary cytokines, includ-
ing IL-6, and numerous chemokines, which may further con-
tribute to the septic syndrome.
It should be emphasized that the systemic effect of these
cytokines are quite different from their local effects, which are
well tolerated by the organism as a whole. The ‘intended’
function of TNF, acting at short range, probably entails
recruitment and activation of neutrophils, ‘walling off’ of an
infectious focus, and local upregulation of antigen presenting
molecules that contribute to the development of an adaptive
immune response. Similarly, IFN-γ favors a T-helper-1
response by the adaptive immune system, in which granu-
loma formation and intense activation of macrophages prevail.
Hence, it may contribute to the more tardive adaptive defense
against pathogens that have been temporarily contained by
the innate immune response.
The principal receptors that engender a local
or systemic inflammatory response
Awareness of the chief effectors of innate immunity provided
end-points to follow in identifying the initial events that tran-
spire during infection. For the most part, TNF production was
taken as a biologically relevant marker of infection, and was
used to identify the receptors that sense host invasion and
transduce the essential signal across the membrane of the
effector cells.
A remarkable new family of receptors, named ‘Toll-like recep-
tors’ (TLRs) in view of their relationship to the prototypic
protein Toll in Drosophila, have recently been identified as
sensors that are believed to directly engage and recognize
microbial LPS [32–34], lipopeptides and peptidoglycan
[35,36], DNA [37], flagellin [38], double-stranded RNA [39],
and probably other conserved determinants as well. The
TLRs are exceptionally powerful exponents of the response to
infection, and without them the mammalian innate immune
system would be largely blind to the presence of infectious
organisms.
The TLRs are single spanning transmembrane proteins that
are coupled to a wide array of signaling molecules within the
cell. All of the TLRs (of which 10 are recognized in humans)
have a conserved TIR motif in the cytoplasmic domain and, as
far as is known, require MyD88 (a cytoplasmic TIR-bearing
protein) for signal transduction, at least in some measure
[40–42].
The best studied TLR is TLR4, the mammalian LPS receptor.
Its function was elucidated by positional cloning [32,43],
through which it was proved that endotoxin resistant mice
bear mutations in the Tlr4 gene and that these mutations
prevent LPS sensing. LPS sensing also depends on a small
protein known as MD-2, which is required for TLR4 surface
expression and signaling [44], and on at least one other mole-
cule, encoded by a locus termed Lps2. This latter locus has
recently been identified through forward genetic studies [45].
Sepsis in flies: Toll and Drosophila
Although insects are dramatically different from mammals in
terms of gross anatomy and physiology, similarities at the cel-
lular level are compelling. Lacking an adaptive immune
system altogether, they do possess an innate immune
system, which was well entrenched in the last common
ancestor of insects and mammals as much as 800 million
years ago. Insects are remarkably resistant to septic injury
and depend largely on the production of antimicrobial pep-
tides for defense. These peptides are induced at the tran-
scriptional level by NF-κB like proteins. In Drosophila, Dif and
Relish are the NF-κB homologs that induce the synthesis of
antimicrobial peptides such as diptericin and drosomycin.
Analysis of mutant flies that are incapable of responding to
various pathogens has greatly enlightened our understanding
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Figure 1
The relationship between Toll-like receptor (TLR)4, tumor necrosis
factor (TNF), and IL-1. Nuclear factor-κB (NF-κB) produced in
response to signals traversing TLR4 (or other TLRs) stimulates the
transcription of inflammatory cytokine genes, including TNF and IL-1.
The cytokines that are produced, in turn, trigger receptors that also
activate NF-κB, via Toll/IL-1/resistance (TIR) domain containing
receptors (in the case of IL-1) or TNF-family receptors (in the case of
TNF). Hence, there is the potential for an amplification loop, dampened
by feedback inhibition of the TLR4 pathway (endotoxin tolerance). IL-
1R, IL-1 receptor; LPS, lipopolysaccharide; RIP, receptor interacting
protein; TNFR, TNF receptor.
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of the biochemical pathways that are activated in insects fol-
lowing infection. A large volume of work has led to the con-
clusion that Toll (a plasma membrane protein that is important
in fly embryogenesis) serves in the adult organism as a
sensor of infection by fungi [46] or Gram-positive bacteria
[47,48], which make their presence known by activating a
proteolytic cascade that leads to a generation of protein
ligand called Spätzle. When Spätzle binds to Toll, it triggers
activation of Drosophila MyD88, as well as proteins called
Tube and Pelle (a homolog of the mammalian IL-1 receptor
associated kinase [IRAK]), which in turn signal the activation
of Dif (a homolog of NF-κB) and then the production of
antimicrobial peptides.
Flies possess a separate signaling pathway, known as the imd
(immunodeficiency) pathway, which is activated by a separate
receptor – a member of the peptidoglycan recognition protein
family of proteins in the fly. Imd itself is a homolog of the mam-
malian protein RIP, and the imd signaling pathway overall
resembles the TNF signaling pathway of mammals very closely
[49]. Although flies do not have a TNF homolog, they have
retained the same ancestral signaling pathway that was inher-
ited by mammals. Although many details remain to be uncov-
ered, the innate immune response in insects appears very
similar in many of its details to that of mammals. It is therefore
possible to draw certain conclusions about what might occur
in mammals from what does occur in flies, and vice versa.
Strikingly, the mammalian equivalents of the Drosophila Toll
and imd pathways have become linked in tandem, through
the remarkably versatile cytokine TNF, which has no counter-
part in flies (Fig. 2). Hence, where two pathways are used for
microbial sensing in the dipteran scheme (Toll for detecting
Gram-positive and fungal pathogens, and imd for detecting
Gram-negative pathogens), the same two pathways are used
sequentially in mammals: first for detecting microbes and
then for amplifying the response to microbes. The situation is
similar to that portrayed for the IL-1 amplification loop in
Fig. 1, in which the TIR domain of the IL-1 receptor signals
the presence of an endogenous protein (IL-1) rather than a
microbial molecule.
Lipopolysaccharide resistance in mammals
and the discovery of Toll-like receptor-4
function
Since 1965, a single mutation was found to abolish LPS
sensing in mice of the C3H/HeJ strain, but to leave most
aspects of immune function intact [50,51]. Animals that could
not sense LPS were more susceptible to infection by several
different types of Gram-negative organisms [52–56]. It was
therefore evident that endotoxin sensing, whatever its risks, is
beneficial overall and necessary to protect the host from a
small inoculum of Gram-negative bacteria.
Genetic mapping studies suggested that this mutation, said
to affect the Lps locus, was present on chromosome 4 [57].
It was not related to LBP and CD14 (mentioned above as
proteins that convey LPS to the surface of responding cells).
Because CD14 has no cytoplasmic domain, it is incapable of
actually transducing the LPS signal. It was widely assumed
that the LPS signal transducer must cross the membrane,
and it was believed that this transducer might be encoded by
the gene that was altered in the C3H/HeJ mouse.
Positional cloning work, in which the position of the mutation
was confined to a narrow chromosomal interval by classical
mapping methods and all sequences within this interval were
examined for mutations, revealed that the lesion altered the
structure of a mammalian homolog of Toll – TLR4 [32].
Hence, one (and only one) of the murine homologs of Toll
confers protection against Gram-negative bacteria, whereas
Toll itself confers protection against fungal and Gram-positive
infection in flies.
Later work, based on transfection studies and gene knock-
outs, revealed that other TLRs detect other microbial prod-
ucts. For example, TLR2 is capable of detecting bacterial
lipopeptides and peptidoglycan [35,36]. TLR5 is capable of
detecting flagellin [38] and TLR9 is capable of detecting
unmethylated DNA from microbial cells [37]. Collectively, the
TLRs are required for all responses to microbes and ‘light the
fire’ of septic shock. Where endotoxin is concerned, the
entire lethal signal is transduced through a few nanograms of
TLR4 protein on macrophages throughout the body of a
mouse (and perhaps shock may be initiated via a few micro-
grams of TLR4 protein in a human).
Reverse genetics and forward genetics:
further analysis of signaling pathways in
sepsis
Two fundamental approaches have guided discovery in the
innate immune field (Fig. 3). ‘Forward genetics’ is an
approach that begins with phenotype and leads to the gene.
Equivalent to the classical genetic method practiced by
Mendel, Morgan, Bridges, and their heirs, forward genetics
may be applied in many different genetic model organisms. In
flies, and in mice, it has led to the elucidation of the key pro-
teins of the innate immune response.
‘Reverse genetics’ is an approach that ends with phenotype.
More precisely, the function of a protein is deduced, where such
function was previously unknown. Reverse genetic methods
include the over-expression of a gene in mammalian cells or in
whole organisms, or alternatively the deletion of the gene in
question, so that a deficiency state can be studied. Reverse
genetic methods have been used to study the mammalian TLRs,
and have led to the general conclusion that each TLR has a sep-
arate and nonoverlapping function in microbial sensing.
However, several of the TLRs currently remain orphans. None
appears to be involved in development, and in Drosophila,
among the nine ‘Tolls’ (paralogs of the original Toll protein) that
are known to exist, only Toll itself has an immune function.
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In practice, where mice are concerned, forward genetics
depends on the use of powerful mutagens such as N-ethyl-N-
nitrosourea, which can induce germ-line mutations at a high
frequency. In order to determine which genes are required for a
robust innate immune response, the investigator maintains
close surveillance over innate immunity, measuring indepen-
dent parts of the innate immune response or the global ability
to defend against a specific type of infection. Mice with an
abnormal phenotype are isolated, transmissibility is demon-
strated, and the mutation responsible is mapped using a
genome-wide panel of markers. Ultimately, if mapping is per-
formed to sufficiently high resolution, then the mutation that is
responsible can be identified, and the gene of note cloned.
As mentioned above, the function of the mammalian TLRs
was first indicated by a forward genetic approach applied to
a spontaneous mutation: the positional cloning of Lps and its
identification as Tlr4. Since that time, at least one new muta-
tion that abolishes much of the endotoxin response has been
identified. This mutation has been designated Lps2 [45]
(Fig. 2). Increasingly, it appears that mammalian microbial
sensors may be quite complex, involving the participation of
numerous proteins. That some of the molecular components
of these receptors may be shared is not excluded.
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Figure 2
The Toll-like receptor (TLR) and tumor necrosis factor (TNF) pathways, represented as Toll and imd pathways in Drosophila, are arranged in
tandem in the mammalian host, and are connected by the cytokine TNF (which does not exist in flies). Each pathway has the effect of activating
nuclear factor-κB (NF-κB), although the second (TNF receptor) limb of the pathway may affect different cells than the first (TLR) limb. FADD, Fas
associated death domain protein; IRAK, interleukin-1 receptor associated kinase; LBP, lipopolysaccharide-binding protein; LPS,
lipopolysaccharide; PI3K, phosphatidylinositol-3 kinase; RIP, receptor interacting protein; SAPK, stress activated protein kinase; TAK, transforming
growth factor-β activated kinase; TNFR, TNF receptor; TRADD, TNF-receptor associated death domain protein; TRAF, tumor necrosis factor
receptor associated factor.
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Practical application of forward and reverse genetics.
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What proteins remain?
The canonical signaling pathway used by the TLRs is one in
which MyD88 is recruited following the engagement of a
microbial ligand, with the subsequent recruitment of IRAK4
[58], through a death domain interaction. IRAK4, in a manner
not yet understood, recruits TRAF6 to the activation complex.
This, in turn, leads to the activation of the transforming growth
factor-β activated kinase (TAK)1, and then to the phosphory-
lation of IκB, with its disassociation from NF-κB. NF-κB acti-
vates many of the genes that are induced by LPS. However, it
is known that other events transpire as well. Numerous
kinases within the cell (including the mitogen activated
protein kinases [59], stress activated protein kinases [60],
p38 kinases [61], and phosphatidylinositol 3-kinase [62]) are
activated by LPS. MyD88 is not absolutely required for the
full spectrum of cellular events that follow induction by LPS
[41]. MyD88 deficient mice still show phosphorylation of p38
mitogen activated protein kinase, for example, which occurs
in normal mice as well, and which depends on events that are
presently not well understood. There are numerous gaps in
the signaling pathway. The junction between TRAF6 activa-
tion and TAK1 activation is not a solid one, or is it clear that
TAK1 directly phosphorylates IκB. There is certainly room for
other proteins, both outside the cell and within it. Forward
genetic analysis perhaps offers the best approach for finding
some of these participants, although it has not yet enjoyed the
tremendous success in mammals that it has in Drosophila – a
model organism with several advantages from the genetic
point of view.
Conclusion
The dramatic advances that have occurred within the past
4 years in our understanding of how cytokine storm is elicited
during severe infection offer a good deal of promise. Although
success in treating sepsis with individual cytokine inhibitors
has not been achieved to date, there is reason to think that a
more global strategy of inhibition might possibly succeed in
quelling the systemic response that we know as sepsis. If it is
accepted that the innate immune system arose primarily to
contain local challenges of microbes (surely the most common
type of insult that occurs in nature), then it might be granted
that the system is somewhat inept at the containment of over-
whelming infection. It might also be granted that antibiotics are
a useful tool for destroying bacteria that have escaped the
primary focus of infection. If both of these proposals were
accepted, then it would appear logical to block the innate
immune response systemically while maintaining bacteriosta-
sis with antibiotics in an effort to treat the patient.
Several molecules already present attractive targets in this
regard. MyD88 and IRAK4 are very broadly involved in signal
transduction, and regardless of the type of microbe that is
involved global dampening of the LPS signal might be
achieved by drugs that inhibit transduction through these
molecules [63]. Already, forward genetic data suggest that
other ‘choke points’ may also exist, insofar as some mutations
appear to forbid signaling in a relatively broad way (Hoebe K
et al., in preparation).
Not only infectious diseases but perhaps autoimmune dis-
eases also may be approached by blockade of TLR path-
ways. Autoimmune exacerbations sometimes occur in the
setting of infection, and it is possible that the primary genetic
lesions in autoimmunity involve components of the same
system that induces cytokine production in the course of an
infection. Here, too, forward genetic methods may have an
important role to play.
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